FDA Approvals - FDA Collaborates To Work Against Rare Cataract ConditionToxic Anterior Segment
FDA Collaborates To Work Against Rare Cataract Condition
Toxic Anterior Segment Syndrome (TASS) is a rare condition that can occur after cataract surgery. The U.S. Food and Drug Administration in collaboration with other Government agencies, unveiled a program today to monitor medical devices used in cataract surgery in an effort to stem outbreaks of the rare, inflammatory condition...
Ranbaxy Announces Consent Decree With U.S. Food And Drug Administration
Ranbaxy Laboratories Ltd. ("Ranbaxy") recently announced that it has signed a consent decree with the U.S. Food and Drug Administration ("FDA").
Durezol And Durasal, Don't Get Them Mixed Up, FDA Warns
Eye drug Durezol (difluprednate ophthalmic emulsion) and wart remover Durasal (salicylic acid) may sound similar, but getting them mixed up can happen, and with potentially serious consequences, the Food and Drug Administration has warned doctors, pharmacists and other health care professionals. The Agency cites a case in which a pharmacist dispensed the wart-remover instead of eye drops to an ...